This Month
May 2006
Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31
Year Archive
Login
User name:
Password:
Remember me 
Contact Information:

For More Information Contact: Rimon Therapeutics Limited 59 Adelaide St. East Suite 500 Toronto, Ontario Canada, M5C 1K6, 416-977-2003 (office), 416-977-6383 (fax), info@rimontherapeutics.com (email) or visit our website at: www.rimontherapeutics.com

Media Contact: Howard Oliver, What If What Next, 416-638-8582, holiver@whatifwhatnext.com.

 

BioFinance 2006 Coverage: Comments by Michael Stinson, Executive Director, BioFinance

“There are a number of highlights this year for me. First, I'm very pleased with the number of high quality presenting companies, 106 in all, an excellent group. CEOs gave the majority presentations generating a lot of interest and enthusiasm. Second, there is a lot of money in the room from Canadian and US VCs, Investment Bankers and Portfolio Managers.”

 

Michael Stinson Executive Director, BioFinance Canada, MaRS Centre

Posted to: 
No comments found.
Trackbacks

TrackBack URL:
http://rimon.blogware.com/blog/_trackback/1949792

No trackbacks found.
Post comment:
Format Type: 
  Convert newlines
  Receive comment notifications for this article
Subject: 
   
insert bold tags insert italic tags insert underline tags insert strikethough tags insert link insert blockquote tags
Comment: 
Comment verification:

Please enter the text you see inside the graphic to post your comment:
This blog does not allow anonymous comments. Please provide your username and password along with your comment.
Login information:
Username: 
Password: 
If you would like to post contact information on your comment, please enter your information into the optional fields below:
Contact information:
URL:  example: http://yourdomain.com